<DOC>
	<DOCNO>NCT01428037</DOCNO>
	<brief_summary>The purpose study estimate efficacy safety 25mcg vaginal misoprostol cervical ripen induction labour .</brief_summary>
	<brief_title>Safety Efficacy Study Vaginal Misoprostol Cervical Ripening Induction Labor</brief_title>
	<detailed_description>There many pregnant woman require medical intervention induce labor reason term . There two fundamental change characterize pre-labor preparation delivery : sensitization myometrium produce contraction , ripen ( soften dilation ) cervix . A synthetic Prostaglandin misoprostol fundamental change . Low dose misoprostol effective safe labor induction use widely . Oral tablet ( 200mcg ) broken fragment use intravaginally ripen cervix induce labor due disadvantage exist cervical ripeners ( delivery bolus dos , freezer refrigerate storage , lack efficacy labor induction ) , due safety concern off-label use oral misoprostol tablet fragment , Regenex Corporation develop vaginal tablet 25mcg misoprostol . The primary objective study assess efficacy safety low dose ( 25 mcg ) misoprostol vaginal tablet cervical ripen induction labour .</detailed_description>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Singleton pregnancy . Aged 20 year old . At term ( 37 42 week inclusive gestation ) . Cephalic presentation ( normal lie ) . No rupture . Bishop score â‰¤6 . With indication labour induction . Written informed consent . Any contraindication vaginal delivery . Previous uterine scar ( Cesarean section uterine surgery ) . Heavy repeat vaginal bleeding third trimester pregnancy . Have history glaucoma , asthma epilepsy . Contraindication prostaglandin use . Known severe allergy prostaglandin . Placenta previa Premature rupture membrane Placental abruption Fetal malpresentation ( Breech Transverse ) Obvious cephalopelvic disproportion Amniotic Fluid Index 250mm less 50mm Fetal growth restriction Fetal malformation Fetal distress Preeclampsia eclampsia Fetal macrosomia prenatal diagnosis ( Btype ultrasonic inspection/Abdomen estimate ) Intrahepatic cholestasis syndrome ( ICP ) Pregnancy severe heart , lung , liver , kidney , endocrine disease immune dysfunction Pregnancy acute systemic infection Pregnancy Severe anemia Cervical carcinoma Some genital tract infection disease , active herpes infection Take part clinical trial within three month . The person investigator think enrol .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Vaginal Misoprostol</keyword>
	<keyword>Cervical Ripening</keyword>
	<keyword>Labor Induced</keyword>
</DOC>